Semaglutide's CHMP Backing Stipulates Post-Approval Safety Studies

 
• By Sten Stovall
  
Recommended
Novo Nordisk's Ozempic (semaglutide) Gets Recommended For Approval By EMA's CHMP • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip